Kiran K Velpula

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Embryonic Stem Cells

Pulmonary Fibrosis

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Maheedhara R Guda, Andrew J Tsung, Swapna Asuthkar, Kiran K Velpula
Galectin-1 activates carbonic anhydrase IX and modulates glioma metabolism. Cell death & disease 13 (6) (2022)
Swapna Asuthkar, Sujatha Venkataraman, Janardhan Avilala, Katherine Shishido, Rajeev Vibhakar, Bethany Veo, Ian J Purvis, Maheedhara R Guda, Kiran K Velpula
SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma. Cancers 14 (7) (2022)
Maral Aminpour, Marco Cannariato, Angelica Zucco, Elisabetta Di Gregorio, Simone Israel, Annalisa Perioli, Davide Tucci, Francesca Rossi, Sara Pionato, Silvia Marino, Marco Agostino Deriu, Kiran K Velpula, Jack Adam Tuszynski
Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19. Biomedicines 9 (9) (2021)
Willie Elliott, Maheedhara R Guda, Swapna Asuthkar, Narasaraju Teluguakula, Durbaka V R Prasad, Andrew J Tsung, Kiran K Velpula
PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis. Biomedicines 9 (12) (2021)
John L Caniglia, Maheedhara R Guda, Swapna Asuthkar, Andrew J Tsung, Kiran K Velpula
A potential role for Galectin-3 inhibitors in the treatment of COVID-19. PeerJ 8 (2020)
Ian J Purvis, Kiran K Velpula, Maheedhara R Guda, Daniel Nguyen, Andrew J Tsung, Swapna Asuthkar
B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role. International journal of molecular sciences 21 (19) (2020)
Maheedhara R Guda, Kiran K Velpula, Swapna Asuthkar, Charlie P Cain, Andrew J Tsung
Targeting RGS4 Ablates Glioblastoma Proliferation. International journal of molecular sciences 21 (9) (2020)
John L Caniglia, Swapna Asuthkar, Andrew J Tsung, Maheedhara R Guda, Kiran K Velpula
Immunopathology of galectin-3: an increasingly promising target in COVID-19. F1000Research (2020)
John L Caniglia, Swapna Asuthkar, Andrew J Tsung, Maheedhara R Guda, Kiran K Velpula
Immunopathology of galectin-3: an increasingly promising target in COVID-19. F1000Research 9 (2020)
Maheedhara R Guda, Collin M Labak, Sara Ibrahim Omar, Swapna Asuthkar, Subra Airala, Jack Tuszynski, Andrew J Tsung, Kiran K Velpula
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets. Cancers 11 (9) (2019)